Human Pharmaceutical Portfolio
Biomab 50 mg Injection
Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.